Recombinant Staphylococcus aureus Carbamoyl-phosphate synthase small chain (carA)

Shipped with Ice Packs
In Stock

Description

Protein Characteristics

Recombinant CarA (UniProt ID: P99147) is expressed as a 366-amino acid polypeptide with a molecular weight of approximately 43 kDa . Key properties include:

PropertyDetail
Expression SystemYeast
Purification TagPolyhistidine (His tag)
Purity>90%
ApplicationsELISA, structural studies, enzymatic assays
StorageLyophilized in PBS (pH 7.4) with 50% glycerol; stable at -20°C or -80°C

The protein retains functionality in its recombinant form, enabling studies on CPSase activity and bacterial metabolism .

Antimicrobial Development

Mutations in the pyr operon (regulated by pyrR), which interacts with CPSase products, alter S. aureus colonization and transmission dynamics . Inhibiting CarA could disrupt pyrimidine biosynthesis, offering a therapeutic target.

Host-Pathogen Interactions

Carbamoyl phosphate synthesis is critical for S. aureus survival in nutrient-limited environments (e.g., host tissues). Studies show that metabolic adaptations in CPSase enhance bacterial persistence during infection .

Key Research Findings

  • Genetic Variability:
    carA is highly conserved in S. aureus, but recombination events in metabolic genes (e.g., aroA) suggest adaptive evolution under host-specific pressures .

  • Colonization Fitness:
    Mutations in pyrR (linked to CPSase regulation) improve gastrointestinal colonization in murine models, highlighting metabolic flexibility as a virulence factor .

Challenges and Future Directions

  • Drug Resistance:
    CPSase inhibitors must circumvent redundancy in bacterial pyrimidine acquisition pathways.

  • Structural Optimization:
    Engineering recombinant CarA with stability tags (e.g., His tag) improves yield for high-throughput screening .

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format. For specific format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchasing method and location. Consult local distributors for specific delivery times. All proteins are shipped with blue ice packs by default. For dry ice shipment, contact us in advance (extra fees apply).
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
carA; pyrAA; SA1045; Carbamoyl-phosphate synthase small chain; EC 6.3.5.5; Carbamoyl-phosphate synthetase glutamine chain
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-366
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Staphylococcus aureus (strain N315)
Target Names
carA
Target Protein Sequence
MQSKRYLVLE DGSFYEGYRL GSDNLTVGEI VFNTAMTGYQ ETISDPSYTG QIITFTYPLI GNYGINRDDF ESLVPTLNGI VVKEASAHPS NFRQQKTLHD VLELHQIPGI AGVDTRSITR KIRQHGVLKA GFTDRKEDID QLVKHLQQVE LPKNEVEIVS TKTPYVSTGK DLSVVLVDFG KKQNIVRELN VRGCNVTVVP YTTTAEEILA MAPDGVMLSN GPGNPEVVEC AIPMIQGILG KIPFFGICLG HQLFALSQGA SSFKMKFGHR GANHPVKNLE TGKVDITSQN HGYAIDIDSL KSTDLEVTHL ALNDGTVEGL KHKTLPAFSV QYHPEANPGP SDSNYLFDDF VAMMTNFKEK ERHINA
Uniprot No.

Q&A

How does Staphylococcus aureus CarA interact with the carbamoyl phosphate synthetase large subunit?

The interaction between CarA and the large subunit (CarB) creates a heterodimeric enzyme with a sophisticated molecular tunnel system. In characterized bacterial CPS enzymes, this tunnel spans approximately 100 Angstroms and connects three separate active sites . The small subunit contains the glutaminase domain, while the large subunit contains two phosphorylation domains.

The molecular interface between the subunits is critical for:

  • Forming the ammonia tunnel that protects the reactive intermediate from the aqueous environment

  • Coordinating the multi-step reaction where ammonia produced by CarA must reach the carboxyphosphate intermediate in CarB

  • Enabling the allosteric regulation of glutaminase activity

These structural arrangements ensure that glutamine hydrolysis is coupled to carbamoyl phosphate formation, preventing wasteful glutamine consumption when the other substrates are unavailable.

What expression systems yield optimal activity for recombinant Staphylococcus aureus CarA?

Escherichia coli has been successfully used as an expression host for recombinant S. aureus proteins, including CarA . When expressing S. aureus CarA, several factors influence protein quality and yield:

Expression SystemAdvantagesConsiderations
E. coli BL21(DE3)High yield, economical, rapid growthMay require optimization of induction conditions
E. coli RosettaAddresses rare codon usage issuesHelpful if S. aureus codon bias affects expression
Yeast expressionBetter for proteins requiring eukaryotic folding machineryLonger expression time, more complex system
Baculovirus/insect cellsSuperior for complex proteins, better foldingHigher cost, longer production time, used successfully for CPS1

For recombinant S. aureus CarA expression, the following parameters have proven effective:

  • N-terminal His-tag (6xHis) for purification

  • Induction at lower temperatures (16-20°C) to improve protein solubility

  • Co-expression with chaperones if inclusion body formation is problematic

Purified recombinant CarA protein has been successfully used for applications including ELISA development .

How can researchers assess the functional activity of recombinant Staphylococcus aureus CarA?

Assessing CarA activity presents challenges since it normally functions as part of the CPS complex. Several approaches can be implemented:

  • Glutaminase Activity Assay: Measuring the hydrolysis of glutamine to glutamate independent of the complete CPS reaction.

    • Detection methods include:

      • Colorimetric detection of released ammonia using Nessler's reagent

      • Coupled enzyme assays that detect glutamate formation

      • Isotopic assays using labeled glutamine

  • Reconstitution Assays: Combining purified recombinant CarA with CarB to reconstitute full CPS activity.

    • The complete reaction can be measured by:

      • Detection of carbamoyl phosphate formation

      • ATPase activity (two ATP molecules consumed per reaction cycle)

      • Formation of downstream metabolites like citrulline or carbamoyl aspartate

  • Binding Studies: Assessing the interaction between CarA and CarB subunits.

    • Techniques include:

      • Surface plasmon resonance

      • Isothermal titration calorimetry

      • Pull-down assays using tagged proteins

When designing activity assays, it's important to include the necessary cofactors such as magnesium for ATP binding and potentially allosteric regulators that may enhance enzyme activity .

What buffer conditions optimize stability and activity of recombinant Staphylococcus aureus CarA?

Based on available data for recombinant S. aureus proteins, including CarA, the following buffer conditions support protein stability and function:

Buffer ComponentRecommended RangeNotes
Primary buffer40 mM Tris-HCl, pH 7.4-8.0Maintains physiological pH range
Salt110-150 mM NaClProvides ionic strength for stability
Additional ions2-3 mM KClSupports protein folding
Stabilizers20% glycerolPrevents aggregation during storage
Detergents0.04% Tween-20Reduces non-specific interactions (optional)
Storage temperature-20°C or -80°CFor extended storage

For active enzyme preparations, additional considerations include:

  • Addition of reducing agents (DTT or β-mercaptoethanol) to maintain cysteine residues in reduced state

  • Inclusion of protease inhibitors to prevent degradation

  • Avoidance of repeated freeze-thaw cycles, which can significantly reduce enzymatic activity

What purification strategies yield the highest purity and activity for recombinant Staphylococcus aureus CarA?

Purification of recombinant S. aureus CarA can be optimized using the following multi-step approach:

  • Affinity Chromatography:

    • Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin for His-tagged CarA

    • Typical elution conditions: 250-300 mM imidazole in purification buffer

    • Critical wash steps with 10-20 mM imidazole to remove non-specifically bound proteins

  • Secondary Purification:

    • Ion exchange chromatography based on CarA's theoretical pI

    • Size exclusion chromatography to remove aggregates and ensure homogeneity

    • Removal of His-tag using TEV or thrombin protease if tag interferes with activity studies

  • Quality Control Assessments:

    • SDS-PAGE analysis to verify >90% purity

    • Western blot to confirm identity

    • Dynamic light scattering to evaluate homogeneity

    • Mass spectrometry for definitive molecular weight determination

The purification protocol should be designed to minimize time and maximize protein stability, as extended purification times can lead to protein degradation or loss of activity.

How can researchers investigate the interaction between Staphylococcus aureus CarA and the large subunit (CarB)?

Multiple complementary approaches can be employed to characterize the CarA-CarB interaction:

  • Co-expression and Co-purification:

    • Co-express both subunits in E. coli with different tags

    • Use tandem affinity purification to isolate the complex

    • Analyze complex formation by size exclusion chromatography

  • Biophysical Characterization:

    • Surface plasmon resonance (SPR) to determine binding kinetics

    • Isothermal titration calorimetry (ITC) for thermodynamic parameters

    • Analytical ultracentrifugation to assess complex stoichiometry

  • Structural Biology Approaches:

    • X-ray crystallography of the complex (as done for E. coli CPS)

    • Cryo-electron microscopy for visualization of the heterodimeric structure

    • Hydrogen-deuterium exchange mass spectrometry to map interaction surfaces

  • Functional Studies:

    • Mutational analysis of predicted interface residues

    • Activity assays comparing individual subunits versus the complex

    • Cross-linking experiments to capture transient interactions

Understanding this interaction is crucial as the formation of the CarA-CarB complex is essential for the coordinated multi-step reaction and the formation of the ammonia tunnel that connects the active sites .

What site-directed mutagenesis approaches can identify critical residues in Staphylococcus aureus CarA?

Based on knowledge from homologous enzymes, several targeted mutagenesis strategies can be employed:

Each mutant should be characterized through activity assays, stability measurements, and structural analyses to build a comprehensive understanding of structure-function relationships in S. aureus CarA.

How can Staphylococcus aureus CarA be utilized as a potential antimicrobial target?

S. aureus CarA represents a potential antimicrobial target due to several favorable characteristics:

  • Essential Metabolic Function:

    • CarA participates in the biosynthesis of pyrimidines and arginine, which are essential for bacterial survival

    • Inhibition would disrupt multiple metabolic pathways simultaneously

  • Structural Distinctions from Human Enzymes:

    • Bacterial CPS differs significantly from human carbamoyl phosphate synthetases

    • These differences could be exploited to develop selective inhibitors with minimal host toxicity

  • Target Validation Approaches:

    • Conditional knockout studies to confirm essentiality in S. aureus

    • Chemical genetics using partial inhibitors to validate vulnerability

    • Mouse infection models to demonstrate in vivo relevance

  • High-Throughput Screening Strategies:

    • Development of activity assays suitable for screening compound libraries

    • Virtual screening against the CarA structure or homology model

    • Fragment-based approaches to identify initial binding scaffolds

The unique molecular tunnel architecture and the requirement for CarA-CarB interaction present specific opportunities for inhibitor development that could disrupt either catalytic function or essential protein-protein interactions .

What techniques are most appropriate for elucidating the three-dimensional structure of Staphylococcus aureus CarA?

Multiple complementary techniques can be employed to determine the structure of S. aureus CarA:

  • X-ray Crystallography:

    • The gold standard for high-resolution protein structures

    • Critical considerations include:

      • Protein purity >95% with monodisperse behavior

      • Optimization of crystallization conditions

      • Co-crystallization with substrates or inhibitors to capture different conformational states

  • Cryo-electron Microscopy:

    • Increasingly powerful for medium to high-resolution structures

    • Particularly valuable for visualizing CarA in complex with CarB

    • Does not require protein crystallization, which can be challenging

  • NMR Spectroscopy:

    • Useful for studying protein dynamics and ligand interactions

    • May be limited by the size of CarA (~40 kDa)

    • Requires isotopically labeled protein

  • Computational Approaches:

    • Homology modeling based on E. coli CPS structure

    • Molecular dynamics simulations to study conformational changes

    • Integration with experimental data from limited proteolysis or crosslinking

A multi-technique approach would provide the most comprehensive structural understanding, capturing both static architectural features and dynamic conformational changes associated with catalysis and regulation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.